Skip Navigation


NDT Advance Access originally published online on August 25, 2007
Nephrology Dialysis Transplantation 2008 23(1):201-206; doi:10.1093/ndt/gfm572
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
23/1/201    most recent
gfm572v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Day, C.
Right arrow Articles by Lipkin, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Day, C.
Right arrow Articles by Lipkin, G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2007]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org



The role of renal biopsy in women with kidney disease identified in pregnancy

Clara Day1, Peter Hewins1, Sarah Hildebrand1, Lumaan Sheikh2, Gabrielle Taylor1, Mark Kilby2 and Graham Lipkin1

1Dept of Nephrology, University Hospital, Birmingham NHS Foundation Trust, Edgbaston, Birmingham B15 2TH and 2Dept of Fetal Medicine, Birmingham Women's; Health Care NHS Trust, Birmingham, B15 2TG

Correspondence to: Dr Graham Lipkin, Queen Elizabeth Hospital, Edgbaston, Birmingham B15 2TH, UK. Email: graham.lipkin{at}uhb.nhs.uk



  Abstract

Background. Renal disease may present for the first time in pregnancy, either as symptomatic disease or as a consequence of antenatal screening. The role of antenatal and post-partum percutaneous renal biopsy in the management of such patients is discussed.

Methods. We describe two series of women; the first is a series of 20 women presenting with renal disease of a severity to warrant renal biopsy during pregnancy whilst the second, comprises 75 women who had an initial presentation of renal disease in pregnancy and underwent post-partum renal biopsy.

Results. Biopsy during pregnancy revealed a glomerular disorder in 19/20 (95%) with immediate change of management in 9/20 (40%). In 17/20 (85%) there was delivery of a live infant at median gestation of 36 weeks (range 25–40). Follow-up of women [median 103.3 months (2.5–256)] showed 9/20 (45%) had a GFR of <60 ml/min/1.73 m2 [six at end-stage renal failure (ESRF)] and 3/20 were dead. The majority (62/75; 82.6%) of women undergoing post-partum renal biopsy presented with significant proteinuria (40% pre-eclampsia) during pregnancy not resolving post-partum. A glomerular abnormality was found in 64%. At last follow-up of 47 women [median 51.5 months (range 1–212)], 14 patients (29.7%) had significant proteinuria and 20 (42.6%) had a GFR<60 ml/min/1.73 m2. Six women (12.7%) had ESRF.

Conclusions. Diagnosis and follow-up of renal disease diagnosed in pregnancy is important as progressive disease occurs in this group. Routine antenatal screening provides a useful diagnostic opportunity to detect asymptomatic renal disease. In a selected sub-group, renal biopsy during pregnancy can be helpful in initiation of correct treatment and allowing progression of pregnancy to fetal viability.

Keywords: chronic kidney disease; pre-eclampsia; pregnancy; proteinuria; renal biopsy

Received for publication: 11. 2.07
Accepted in revised form: 26. 7.07


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.